1071 related articles for article (PubMed ID: 26184998)
1. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
2. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
4. JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.
Facompre ND; Harmeyer KM; Sole X; Kabraji S; Belden Z; Sahu V; Whelan K; Tanaka K; Weinstein GS; Montone KT; Roesch A; Gimotty PA; Herlyn M; Rustgi AK; Nakagawa H; Ramaswamy S; Basu D
Cancer Res; 2016 Sep; 76(18):5538-49. PubMed ID: 27488530
[TBL] [Abstract][Full Text] [Related]
5. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
[TBL] [Abstract][Full Text] [Related]
6. PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma.
Cui Z; Song L; Hou Z; Han Y; Hu Y; Wu Y; Chen W; Mao L
Oncol Rep; 2015 May; 33(5):2454-60. PubMed ID: 25777981
[TBL] [Abstract][Full Text] [Related]
7. JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression.
Shen X; Zhuang Z; Zhang Y; Chen Z; Shen L; Pu W; Chen L; Xu Z
Tumour Biol; 2015 Sep; 36(9):7133-42. PubMed ID: 25877751
[TBL] [Abstract][Full Text] [Related]
8. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
[TBL] [Abstract][Full Text] [Related]
9. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
10. lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.
Li B; Lv Y; Zhang C; Xiang C
J Oral Pathol Med; 2023 Mar; 52(3):216-225. PubMed ID: 36661031
[TBL] [Abstract][Full Text] [Related]
11. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
[TBL] [Abstract][Full Text] [Related]
12. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
13. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
14. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
[TBL] [Abstract][Full Text] [Related]
15. Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis.
da Silva SD; Marchi FA; Xu B; Bijian K; Alobaid F; Mlynarek A; Rogatto SR; Hier M; Kowalski LP; Alaoui-Jamali MA
Oncotarget; 2015 Sep; 6(26):21950-63. PubMed ID: 26110570
[TBL] [Abstract][Full Text] [Related]
16. Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation.
Hayes TF; Benaich N; Goldie SJ; Sipilä K; Ames-Draycott A; Cai W; Yin G; Watt FM
Cancer Lett; 2016 Dec; 383(1):106-114. PubMed ID: 27693639
[TBL] [Abstract][Full Text] [Related]
17. Overexpressed tryptophanyl-tRNA synthetase, an angiostatic protein, enhances oral cancer cell invasiveness.
Lee CW; Chang KP; Chen YY; Liang Y; Hsueh C; Yu JS; Chang YS; Yu CJ
Oncotarget; 2015 Sep; 6(26):21979-92. PubMed ID: 26110569
[TBL] [Abstract][Full Text] [Related]
18. The histone demethylase LSD1 is a novel oncogene and therapeutic target in oral cancer.
Wang Y; Zhu Y; Wang Q; Hu H; Li Z; Wang D; Zhang W; Qi B; Ye J; Wu H; Jiang H; Liu L; Yang J; Cheng J
Cancer Lett; 2016 Apr; 374(1):12-21. PubMed ID: 26872725
[TBL] [Abstract][Full Text] [Related]
19. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia induced Bcl-2/Twist1 complex promotes tumor cell invasion in oral squamous cell carcinoma.
Duan Y; He Q; Yue K; Si H; Wang J; Zhou X; Wang X
Oncotarget; 2017 Jan; 8(5):7729-7739. PubMed ID: 28032603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
